The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy

por Yoshikawa, Reigetsu, Tsujimura, Tohru, Tao, Lihua, Kamikonya, Norihiko, Fujiwara, Yoshinori
Publicado 2012

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

por FUJIWARA, YOSHINORI, YOSHIKAWA, REIGETSU, KAMIKONYA, NORIHIKO, NAKAYAMA, TSUYOSHI, KITANI, KOTARO, TSUJIE, MASANORI, YUKAWA, MASAO, INOUE, MASATOSHI, YAMAMURA, TAKEHIRA
Publicado 2012

Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug

por Tanaka, Keita, Yoshikawa, Reigetsu, Yanagi, Hidenori, Gega, Makoto, Fujiwara, Yoshinori, Hashimoto-Tamaoki, Tomoko, Hirota, Syozo, Tsujimura, Tohru, Tomita, Naohiro
Publicado 2008

Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma

por FUJIWARA, YOSHINORI, YOSHIKAWA, REIGETSU, KAMIKONYA, NORIHIKO, NAKAYAMA, TSUYOSHI, KITANI, KOTARO, TSUJIE, MASANORI, YUKAWA, MASAO, HARA, JOHJI, YAMAMURA, TAKEHIRA, INOUE, MASATOSHI
Publicado 2013

Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial

por Kudo, Masatoshi, Okusaka, Takuji, Motomura, Kenta, Ohno, Izumi, Morimoto, Manabu, Seo, Satoru, Wada, Yoshiyuki, Sato, Shinpei, Yamashita, Tatsuya, Furukawa, Masayuki, Aramaki, Takeshi, Nadano, Seijin, Ohkawa, Kazuyoshi, Fujii, Hirofumi, Kudo, Toshihiro, Furuse, Junji, Takai, Hiroki, Homma, Gosuke, Yoshikawa, Reigetsu, Zhu, Andrew X.
Publicado 2020

Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomi...

por Yoshikawa, Takaki, Muro, Kei, Shitara, Kohei, Oh, Do-Youn, Kang, Yoon-Koo, Chung, Hyun Cheol, Kudo, Toshihiro, Chin, Keisho, Kadowaki, Shigenori, Hamamoto, Yasuo, Hironaka, Shuichi, Yoshida, Kazuhiro, Yen, Chia-Jui, Omuro, Yasushi, Bai, Li-Yuan, Maeda, Kaijiro, Ozeki, Akichika, Yoshikawa, Reigetsu, Kitagawa, Yuko
Publicado 2019

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

por Kudo, Masatoshi, Galle, Peter R., Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S., Llovet, Josep M., Assenat, Eric, Merle, Philippe, Chan, Stephen L., Palmer, Daniel H., Ikeda, Masafumi, Yamashita, Tatsuya, Vogel, Arndt, Huang, Yi-Hsiang, Abada, Paolo B., Yoshikawa, Reigetsu, Shinozaki, Kenta, Wang, Chunxiao, Widau, Ryan C., Zhu, Andrew X.
Publicado 2020